Covidien Aims To Double Sales In Emerging Markets By 2017
This article was originally published in PharmAsia News
Executive Summary
Covidien plans to double its sales in emerging markets, primarily China and India, to $2 billion over the next five to six years, CEO Jose E. Almeida said during the firm's Sept. 8 investor meeting in New York
You may also be interested in...
Emerging Views On Emerging Markets: Goldman Sachs Global Healthcare Conference
PharmAsia News takes a closer look at presentations by Abbott, Covidien and Novartis.
Trends In MIS, Part I: Pushing Surgical Boundaries
The market for minimally invasive surgical products continues to grow, driven by increasing demand and advances in laparoscopic technologies and techniques. Medical device manufacturers are developing new and innovative endomechanical and energy devices, as well as improved camera systems, which are allowing surgeons to safely push surgical boundaries and expand the minimally invasive surgery (MIS) approach into more complex surgical procedures than ever before. From a market perspective, manufacturers are driving growth in the MIS product market by targeting underpenetrated and emerging markets, particularly in Asia and Latin America, and by focusing education, sales, and product development efforts on growing clinical areas with good potential for increasing MIS adoption.
Stryker Buys Concentric Medical To Enter Acute Ischemic Stroke Market
Stryker will gain access to the acute ischemic stroke market by acquiring privately held Concentric Medical for $135 million under a definitive agreement announced Aug. 31.